All human tissue samples used in this study were used according to the medical ethical guidelines described in the Code for Proper Secondary Use of Human Tissue
We confirmed that one particular or much more somatic mutations occurred in 36% of cervical carcinomas, most of them in PIK3CA (24%), followed by KRAS (four%), CTNNB1 (3%), and PPP2R1A…